SARS-CoV-2 Spike receptor binding domain, RBD (336-347) – Lys(Biotin-LC) – 0.1 mg

Overview

The SARS-CoV-2 Spike receptor binding domain (RBD) peptide sequence, specifically residues 336-347, plays a critical role in the interaction with the ACE2 receptor. This peptide is sourced from the spike protein of SARS-CoV-2 and is essential for research related to COVID-19 and vaccine development. Our product is labeled with Biotin-LC at the C-terminus, enhancing its utility for various labeling and detection applications.

Key Features

• Biotinylated RBD peptide for easy detection in assays
• Ideal for studying receptor interactions and cellular entry mechanisms
• High purity and reliable performance in experimental applications
• Facilitates the development of diagnostic and therapeutic strategies
• Extensively used in immunological studies and vaccine research

Specifications

FAQ

What applications is this peptide suitable for?

This biotinylated peptide is excellent for assays requiring receptor binding studies, such as ELISA, and can help in exploring vaccine efficacy and therapeutic strategies.

How should I store this product?

Store the SARS-CoV-2 Spike RBD peptide at -20°C for optimal stability. Ensure that the product is protected from light to maintain its integrity.

Can I use this peptide in live-cell experiments?

While this peptide is designed for in vitro experiments, consult your specific protocol for guidance on using biotinylated peptides within live-cell contexts.

Ready to enhance your research? Buy the SARS-CoV-2 Spike receptor binding domain, RBD (336-347) – Lys(Biotin-LC) peptide today, and explore its vital applications in your studies. For more related products, check out our selection of peptides to find other essential tools for your research.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled